REMEDY is a research center focused on the treatment of rheumatology and musculoskeletal diseases. Their goal is to develop excellent treatments and strategies within this field through a comprehensive approach to research. They aim to conduct high-quality clinical studies that have the potential to change clinical practice. As a collaboration between Diakonhjemmet Hospital, Oslo University Hospital, the University of Oslo, the Norwegian Rheumatism Association, and MAGIC, REMEDY is dedicated to improving patient care in rheumatology and musculoskeletal diseases.

Their research focuses on several areas, including treatment studies to evaluate the effectiveness of medications, surgical procedures, injections, and non-pharmacological interventions. They also strive to identify biomarkers and genetic/epigenetic markers for treatment effectiveness and disease severity, as well as understanding underlying pain mechanisms to optimize treatment. REMEDY is dedicated to developing strategies for detecting, treating, and preventing comorbidity, and they also investigate the usability, effectiveness, and cost-effectiveness of personalized digital follow-up.

In addition, REMEDY operates a national clinical network consisting of rheumatology hospital departments and rehabilitation institutions from all over Norway. Patient involvement in research is central to their work, with a patient council and representatives from the Norwegian Rheumatism Association actively participating in projects. REMEDY is committed to improving research through user involvement.

Stay up-to-date with REMEDY's latest news and developments on their website and social media channels.